Scientists from the University of Pennsylvania have identified an immune-system protein that facilitates the spread of ...

Investigational dopaminergic cell replacement therapy shows safety and preliminary motor improvements in early-phase Parkinson disease clinical trials.

Top line results from the Phase IIb GBA-PD clinical trial are anticipated by the end of the second quarter.

Investigational Oral Candidate JOTROL™ Addresses a Parkinson’s Disease Market with No Current Disease-modifying Therapies AvailableJupiter, FL, ...

Rebecca King Crews talks about how husband Terry first told her about a new FDA approval for focused ultrasound for treating ...

The Parkinson's Foundation recommends that in addition to making an appointment with an internist or family practitioner, a person experiencing symptoms should also see a movement disorders specialist ...

A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD) in certain ...

Please provide your email address to receive an email when new articles are posted on . There is a need to look past dopaminergic therapy and target inflammation for disease modification. Chronic ...

Researchers estimate that 89% of people with Parkinson's disease (PD) have speech and voice disorders including disorders of laryngeal, respiratory and articulatory function. Despite the high ...